Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Nov 18, 2015 at 9:10 AM EST

Jefferies Reveals Top 5 Pharma Stock Picks for Growth and Dividends

Jefferies has updated the thesis behind its "Top 5 for 2015" pharmaceutical stock picks

Chris Lange | Nov 17, 2015 at 11:45 AM EST

Ocera Therapeutics Rises on Positive Phase 1 Results

Ocera Therapeutics broke out in Tuesday's trading session following positive results from a clinical study.

Chris Lange | Nov 16, 2015 at 1:05 PM EST

What Perrigo and Teva Can Learn From Mylan’s Share Repurchase

Mylan announced Monday that it would be conducting a share repurchase for up to $1 billion, in a much faster…

Chris Lange | Nov 16, 2015 at 10:40 AM EST

Clovis More Than Halves on FDA Hurdle

Clovis Oncology was leading the bears in Monday’s trading session on news that its lung cancer drug may be delayed.

Chris Lange | Nov 16, 2015 at 10:35 AM EST

Merck Prepares to Break Into HCV Market With Recent Study Results

Merck is joining the likes of Gilead Sciences in producing hepatitis C vaccines, but it is still in the early…

Jon C. Ogg | Nov 14, 2015 at 9:40 AM EST

Why Being Added into the S&P 500 Matters So Much for Illumina

Being added to the S&P 500 Index comes with a certain amount of prestige. It can also come with a…

Chris Lange | Nov 14, 2015 at 9:20 AM EST

7 BioHealth Movers That Cannot Be Ignored

The biotech companies 24/7 Wall St. has picked stood out from the rest with incredible gains or losses over the…

Chris Lange | Nov 13, 2015 at 11:20 AM EST

Alcobra Gears Up for Secondary Offering

Alcobra has announced the pricing of its underwritten secondary offering for more than 6 million shares.

Chris Lange | Nov 13, 2015 at 11:15 AM EST

Hutchison China MediTech Files for IPO

Hutchison China MediTech has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).

Jon C. Ogg | Nov 11, 2015 at 1:45 PM EST

Why Horizon and Express Scripts Woes Might Make DepoMed Dirt Cheap

In a fresh report, Janney Capital Markets has said that bad news for Horizon Pharma is creating a buying opportunity…

Chris Lange | Nov 11, 2015 at 12:20 PM EST

Wave Life Sciences Sneaks Into the Market With IPO

Wave Life Sciences PTE entered the market Wednesday morning in its initial public offering (IPO).

Jon C. Ogg | Nov 11, 2015 at 11:55 AM EST

Voyager Therapeutics IPO Ticks Up After Lower Pricing

Voyager Therapeutics has debuted after pricing its initial public offering (IPO) under the expected range.

Chris Lange | Nov 11, 2015 at 11:40 AM EST

SurgiQuest Files for IPO

SurgiQuest has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).

Chris Lange | Nov 11, 2015 at 8:15 AM EST

Short Sellers Continue to Decrease Bets in Major Pharma

The short interest data have been released for the October 30 settlement date, and for most of the selected pharmaceutical…

Chris Lange | Nov 11, 2015 at 7:45 AM EST

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the October 30 settlement date, and short interest fell in selected biotech stocks.

1 … 234 235 236 237 238 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Jefferies Reveals Top 5 Pharma Stock Picks for Growth and Dividends

Ocera Therapeutics Rises on Positive Phase 1 Results

What Perrigo and Teva Can Learn From Mylan’s Share Repurchase

Clovis More Than Halves on FDA Hurdle

Merck Prepares to Break Into HCV Market With Recent Study Results

Why Being Added into the S&P 500 Matters So Much for Illumina

7 BioHealth Movers That Cannot Be Ignored

Alcobra Gears Up for Secondary Offering

Hutchison China MediTech Files for IPO

Why Horizon and Express Scripts Woes Might Make DepoMed Dirt Cheap

Wave Life Sciences Sneaks Into the Market With IPO

Voyager Therapeutics IPO Ticks Up After Lower Pricing

SurgiQuest Files for IPO

Short Sellers Continue to Decrease Bets in Major Pharma

Short Sellers Run for Cover From Major Biotechs

If You Had Invested $1,000 in McDonald’s a Decade Ago: A Prospective Dividend King’s Long-Term Payoff

We May Soon Find Out Why Warren Buffett and Berkshire Hathaway Have Almost $400 Billion in Cash

Prospect Capital insiders are buying while yield hunters debate the safety

Caleb Hammer Confronts Husband Hiding an AI Girlfriend From His Wife

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

If You Had Invested $1,000 in McDonald’s a Decade Ago: A Prospective Dividend King’s Long-Term Payoff

We May Soon Find Out Why Warren Buffett and Berkshire Hathaway Have Almost $400 Billion in Cash

Health and Healthcare Articles

All Health and Healthcare Articles

Jefferies Reveals Top 5 Pharma Stock Picks for Growth and Dividends

Ocera Therapeutics Rises on Positive Phase 1 Results

What Perrigo and Teva Can Learn From Mylan’s Share Repurchase

Clovis More Than Halves on FDA Hurdle

Merck Prepares to Break Into HCV Market With Recent Study Results

Why Being Added into the S&P 500 Matters So Much for Illumina

7 BioHealth Movers That Cannot Be Ignored

Alcobra Gears Up for Secondary Offering

Hutchison China MediTech Files for IPO

Why Horizon and Express Scripts Woes Might Make DepoMed Dirt Cheap

Wave Life Sciences Sneaks Into the Market With IPO

Voyager Therapeutics IPO Ticks Up After Lower Pricing

SurgiQuest Files for IPO

Short Sellers Continue to Decrease Bets in Major Pharma

Short Sellers Run for Cover From Major Biotechs

If You Had Invested $1,000 in McDonald’s a Decade Ago: A Prospective Dividend King’s Long-Term Payoff

We May Soon Find Out Why Warren Buffett and Berkshire Hathaway Have Almost $400 Billion in Cash

Prospect Capital insiders are buying while yield hunters debate the safety

Featured Reads

Caleb Hammer Confronts Husband Hiding an AI Girlfriend From His Wife

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70